The expanded window for thrombectomy in acute stroke care ranked No. 3 on Cleveland Clinic’s top 10 medical innovations for 2019—one of several developments on the list with implications for cardiovascular treatment.

A therapeutic vaccine developed in Japan could work as well as oral antithrombotic drugs to prevent secondary ischemic stroke, according to preliminary research published Oct. 29 in Hypertension.

Researchers from Northwestern University developed an easy-to-calculate, four-factor score which identified 92.2 percent of true strokes among 330 inpatients who triggered stroke alerts.

A team of Chicago researchers has identified four genetic variants specific to people of African ancestry which may help explain their increased incidence of warfarin-associated bleeding events.

Aspirin alone may be sufficient to balance the risks of venous thromboembolism (VTE) and bleeding following total knee replacement surgery, according to a study published online in JAMA Surgery.

Recreational marijuana use is linked to an increase in stroke prevalence in the U.S. population, according to a study presented at the 11th World Stroke Congress in Montreal. Results of the study were released just two days after Canada legalized recreational cannabis nationwide.

Avinger announced on Oct. 18 its Pantheris SV atherectomy device has gained CE mark approval, allowing it to be sold commercially in Europe. The system extends the plaque-removing technique for peripheral artery disease to smaller vessels with diameters between 2 and 4 millimeters.

Patients who resume oral anticoagulation treatment following intracerebral hemorrhage (ICH) are almost twice as likely to achieve functional recovery, according to a study published Oct. 9 in Stroke.